In an exceptional murine study design from Pinxteren and colleagues, depletion of CD8+ T cells during the acute stages (days 1–21 post challenge) of infection did not result in higher bacterial burden, whereas depletion during a latent phase (11 weeks post drug treatment) increased pulmonary bacterial burden 10-fold (336). Here, CD8A is linked to infection.